(Total Views: 322)
Posted On: 05/14/2020 3:46:22 PM
Post# of 22462
One would think that the lack of SEC reporting would stop people from coming on board, but QMC evidently has been hiring.
One would think companies and organizations would not trust us, but we see many examples in the webinars and articles that they do.
One would think money would dry up but Squires has been creative in starting QDX Ledger and HealthID, and getting QMVT started for $2 million. Why would the Capstan owners take shares and why would the QMVT partners buy what they did if hey didn't think QMC is viable and poised for big things? And why would AMTRON remain a strong partner? We have never heard any stories that the relationship is not strong, only that last year's monsoon season and this year's Covid-19 outbreak have affected construction.
I speak only for myself, but past discussions on this board from long-term investors in QTMM have said that revenue will cause the stock to rise. Revenue and recurring income.
We have also seen that recently Covid-19 rapid test companies stock rise just on announced FDA approval of their test. So QTMM could rise on anticipation of revenue, too. Does anyone disagree that both revenue and anticipation of revenue from Covid-19 tests or HealthID or both could increase share prices?
My focus is how is QMC doing in laying the groundwork for revenue? I see them making progress in the areas they have talked about, and other areas that are under development. Every day closer.
One would think companies and organizations would not trust us, but we see many examples in the webinars and articles that they do.
One would think money would dry up but Squires has been creative in starting QDX Ledger and HealthID, and getting QMVT started for $2 million. Why would the Capstan owners take shares and why would the QMVT partners buy what they did if hey didn't think QMC is viable and poised for big things? And why would AMTRON remain a strong partner? We have never heard any stories that the relationship is not strong, only that last year's monsoon season and this year's Covid-19 outbreak have affected construction.
I speak only for myself, but past discussions on this board from long-term investors in QTMM have said that revenue will cause the stock to rise. Revenue and recurring income.
We have also seen that recently Covid-19 rapid test companies stock rise just on announced FDA approval of their test. So QTMM could rise on anticipation of revenue, too. Does anyone disagree that both revenue and anticipation of revenue from Covid-19 tests or HealthID or both could increase share prices?
My focus is how is QMC doing in laying the groundwork for revenue? I see them making progress in the areas they have talked about, and other areas that are under development. Every day closer.
(0)
(0)Scroll down for more posts ▼
